Category: Pharmaceuticals
Pharmaceuticals market research reports by Frost & Sullivan
-
Pharmaceutical Clinical Contract Peripheral Services, Global, 2025–2030
As trial volumes normalize after the COVID-19 pandemic, pharma and biopharma companies are re-focusing on their drug development pipelines. As a result, the market has been creating an increasing number of clinical trial outsourcing opportunities for CROs, with these service providers also refining ... Read More
-
Innovations in Restorative Dentistry
Technology is transforming the field of dentistry, driven by continuous advancements in dental materials and 3D printing aimed at improving the appearance, functionality, and durability of dental restorations. Emerging dental materials such as hybrid composites and smart composites, as well as digit ... Read More
-
Top 6 Growth Opportunities in Pharma-Biotech, 2025
The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatme ... Read More
-
Top 10 Strategic Imperatives in the Life Sciences Industry, 2025
Owing to constant developments and challenges in the life sciences industry, stakeholders must continue to be adaptable, innovative, and competitive to thrive. Industry leaders must reconsider their strategic positions annually by understanding the main forces behind the transformation, including po ... Read More
-
Innovations and Growth Opportunities in Electroceuticals for Chronic Diseases
Electroceuticals is a rapidly growing field that is pursuing new and innovative solutions to overcome challenges in treating various pain and neurological disorders. Emerging technologies in these areas attract significant interest because of their potential to revolutionize the field, creating prom ... Read More
-
Technologies Enabling Resilient Pharmaceutical Supply Chains
Technologies Enabling Resilient Pharmaceutical Supply Chains AI-enabled Technologies are Transforming the Pharmaceutical Supply Chain Network This study aims to review emerging, transformative technology solutions that redesign pharmaceutical supply chain processes and introduce increased resilience ... Read More
-
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Top 6 Growth Opportunities for the Digital Health Industry, 2025 Mental Health and Generative AI are Driving Transformational Growth Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must a ... Read More
-
Growth Opportunities in Nutricosmetics Ingredients, Global, 2024–2030
Growth Opportunities in Nutricosmetics Ingredients, Global, 2024–2030 Evolving Consumer Awareness About Holistic Beauty is Driving Transformational Growth Nutricosmetics are a category of products that combine nutrition and cosmetics and offer a holistic method to enhance health and aesthetics throu ... Read More
-
Top 10 Strategic Imperatives in the Nutrition and Wellness Sector, 2024
Top 10 Strategic Imperatives in the Nutrition and Wellness Sector, 2024 The Top Transformations Impacting Future Growth Potential Strategic imperatives are concepts that companies embrace to overcome internal and external challenges, such as economic disruptions that make it difficult to prepare a c ... Read More
-
Innovations and Growth Opportunities in Healthcare Gamification
Innovations and Growth Opportunities in Healthcare Gamification Virtual reality and artificial intelligence to drive transformational growth Healthcare gamification involves the incorporation of game design elements into healthcare practices to enhance patient engagement and improve health outcomes. ... Read More
-
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2024 A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step appro ... Read More
-
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024–2029
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024–2029 Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization With the growing preference for a patient-centric care delivery approach, t ... Read More
-
Precision Neurodegenerative Disease Market, Global, 2024–2028
Precision Neurodegenerative Disease Market, Global, 2024–2028 Precision NDD Treatment is Experiencing Transformational Growth due to AI Capabilities, Disease-modifying Therapies, and Industry Convergence The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symp ... Read More
-
Pipeline Assessment for Cardiovascular Diseases
Pipeline Assessment for Cardiovascular Diseases Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been m ... Read More
-
Growth Opportunities in Emerging Nutricosmetics Technologies, 2024–2029
Growth Opportunities in Emerging Nutricosmetics Technologies, 2024–2029 Increased Focus on Health and Wellness Promoting the Growth of Nutricosmetic Supplements Consumer awareness regarding skin health and how to achieve it has seen significant growth in the past few years. Because of changes in lif ... Read More
-
CGT Research Outlook and Technology Growth Opportunities
CGT Research Outlook and Technology Growth Opportunities CGT Landscape Assessment The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and ... Read More
-
Growth Opportunities in Vitamin and Mineral Ingredients for Human Nutrition, Global, 2024–2030
Growth Opportunities in Vitamin and Mineral Ingredients for Human Nutrition, Global, 2024–2030 Rising Consumer Awareness and Technological Advances Are Driving Transformational Growth Through Personalized Nutrition Vitamins are organic compounds classified based on their solubility into water- and f ... Read More
-
Engineered Antibody Therapeutics for Cancer
Engineered Antibody Therapeutics for Cancer Technology advances and increasing interest from Tier I pharmaceuticals are driving the growth of engineered antibodies This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limi ... Read More
-
Menopause Care Management Technology Growth Opportunities, 2024–2029
Menopause Care Management Technology Growth Opportunities, 2024–2029 Growing competitive intensity fuels future growth potential in menopause care management As the global population ages, more attention should be paid to the needs of individuals aged 45 to 55, particularly women in the perimenopaus ... Read More
-
Connected Diabetes Care: Innovations and Growth Opportunities
Connected Diabetes Care: Innovations and Growth Opportunities Continuous Glucose Monitoring, Artificial Pancreas Systems, and Novel Insulin Delivery Formulations to Transform the Future of Diabetes Management The preference for diabetes self-assessment using wearable CGMs instead of finger-stick blo ... Read More
-
Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024–2028
Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024–2028 Leveraging integrated and point-of-care diagnostics with multiomics represents the most promising growth opportunity to advance molecular diagnostics for neurodegenerative diseases Neurodegenerative dise ... Read More
-
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028 GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID ... Read More
-
Industrial Roboverse—Growth Opportunities in the F&B and Pharmaceutical Industries
Industrial Roboverse Growth Opportunities in the F&B and Pharmaceutical Industries Driving Agile Manufacturing While Maximizing Quality, Efficiency, and Compliance Augments Robotic Adoption This study explores the potential growth opportunities presented by industrial robotics in the food and bevera ... Read More
-
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities
Innovative AI-enabled Clinical Trial Companies: Strategic Profiling and Growth Opportunities The Integration of Real-world Insights into Trial Management is Propelling AI Adoption in Clinical Trials As global clinical pipelines witness a surge in complex novel therapies, there is a general inclinati ... Read More
-
Diabetes Care Devices, Forecast to 2028
Diabetes Care Devices, Forecast to 2028 Growth Opportunities in AI and GLP-1 will Drive the Expansion of Type 2 Diabetes Devices This study provides a detailed overview of the global diabetes care device industry, which is witnessing a significant increase in demand due to the growing prevalence of ... Read More
Research Assistance
